Muscle & Nerve · 2003 · 27 citations · 18 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAntibody CharacterizationAntibody-antigen RecognitionAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune Neurological DisordersAntibodiesAntibody-mediated Neurologic DiseaseAntiganglioside Antibody SyndromesConformational Epitope BindingGanglioside Antibody NeuropathyGuillain-barré Syndrome PathogenesisImmunoglobulin G ResponsesNeuronal Autoantibodies
Anti-GM1 immunoglobulin G (IgG) antibodies are frequently present in sera from patients with Guillain-Barré syndrome (GBS). A previous report on a patient who had a neuropathy with immunoglobulin M (IgM) M-protein binding to a conformational epitope formed by phosphatidic acid (PA) and gangliosides prompted us to investigate the binding of IgG antibodies in GBS sera to a mixture of GM1 and PA (GM1/PA). Of 121 GBS patients, 32 had anti-GM1 IgG antibodies. All 32 also had antibody activity against GM1/PA. Twenty-five (78%) of 32 patients had greater activity against GM1/PA than against GM1 alone. Twelve patients who had no anti-GM1 IgG antibodies had IgG antibody activity against GM1/PA. No GBS patient had IgG antibody against PA alone. In contrast, two rabbit anti-GM1 antisera had greater activity against GM1 alone than against GM1/PA. IgG antibody with greater binding activity against a mixture of GM1 and a phospholipid than against GM1 alone may have an important role in the pathogenesis of GBS and has implications for diagnosis.
18
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Atsuro Chiba, Susumu Kusunoki, Teruo Shimizu et al. · Annals of Neurology · 1992 · 566 citations
Life Sciences, Immunology, Neurology +15
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
Charlene E. Hafer‐Macko, Sung‐Tsang Hsieh, Tony W. Ho et al. · Annals of Neurology · 1996 · 509 citations